Kaleido Biosciences, Inc.KLDOOTCMARKET
Loading
Debt to Assets Over TimeNormalizing
Percentile Rank60
3Y CAGR+35.3%
5Y CAGR-15.3%
Year-over-Year Change
Debt-to-assets ratio
3Y CAGR
+35.3%/yr
Annual compound
5Y CAGR
-15.3%/yr
Recent acceleration
Percentile
P60
Within normal range
vs 5Y Ago
0.4x
Contraction
Streak
3 yr
Consecutive growthNormalizing
| Period | Value | YoY Change |
|---|---|---|
| 2021 | 0.43 | +22.2% |
| 2020 | 0.35 | +42.4% |
| 2019 | 0.25 | +42.1% |
| 2018 | 0.17 | -63.9% |
| 2017 | 0.49 | -51.1% |
| 2016 | 0.99 | - |